This was 2 years ago
LocationHybrid: Warsaw, Poland and online
ProgrammesDuring this workshop, organised by the European Commission in collaboration with the Polish authorities, participants will discuss the next steps in setting up competence centers in semiconductors.
Participants will include representatives of companies, research organisations, national authorities, and other stakeholders with interests in the semiconductor sector.
The setting up of competence centres in semiconductors is a crucial element of the Chips for Europe Initiative, the first pillar of the proposed European Chips Act. A competence centre is a single entity or a coordinated group of entities with complementary expertise, and with not-for-profit objectives, which will be providing services to semiconductor stakeholders, particularly SMEs and mid-caps.
Examples include facilitating access to pilot lines and to the design platform, providing training and skills development, support to finding investors, making use of existing local competencies or reaching out to the relevant verticals. The services should be provided on an open, transparent and non-discriminatory basis.
Semiconductors competence centres could be located in either existing or new institutions across Member States. The goal is to have at least one competence centre in each Member State, and each of them will serve as an entry point to the whole European network.
The workshop will include three sessions:
By the end of the workshop, we aim at having found common ground for the next steps to follow by all involved parties.
The agenda and more information on the workshop can be found on the event website.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Climate, Energy, Mobility Agro-Food, Environment Green Deal
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.